A Cervical Cone Biopsy is typically recommended when abnormal cells are detected in the cervix that may indicate precancerous changes. This is often found during a routine Pap smear or during a colposcopy, a procedure in which the cervix is closely examined with a special magnifying instrument. If these tests show abnormal results, a cone biopsy is performed to remove a tissue sample for further analysis. The biopsy helps doctors determine whether the abnormal cells are pre-cancerous or indicate early stages of cervical cancer, allowing for the appropriate treatment to be initiated.

In addition to identifying precancerous or cancerous cells, a Cervical Cone Biopsy can also be recommended if there are concerns about persistent or unusual cervical changes that do not respond to other treatments. This procedure provides a more detailed diagnosis and helps guide the next steps in care. By accurately identifying the presence and extent of abnormal cells, a cone biopsy plays a critical role in preventing the development of cervical cancer and ensuring that any necessary interventions are implemented at the earliest stage possible.